The GATAD2B Gene Mental Retardation Autosomal Dominant Type 18 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the GATAD2B gene. This gene is associated with Autosomal Dominant Mental Retardation Type 18, a condition that affects cognitive development and may cause other neurological issues. The test plays a crucial role in understanding the genetic basis of the disorder, facilitating early intervention and personalized management strategies for affected individuals. Priced at 4400 AED, this test is a valuable resource for families seeking answers to developmental delays and intellectual challenges within their loved ones, offering them a pathway towards tailored care and support.
The CTNNB1 gene is associated with a condition known as Mental Retardation, Autosomal Dominant Type 19 (MRD19), a disorder characterized by intellectual disability and potentially other neurological or physical abnormalities. Mutations in the CTNNB1 gene, which plays a crucial role in cell signaling and development, are the underlying cause of this condition. These mutations can disrupt normal brain development, leading to the symptoms observed in affected individuals.
Genetic testing for mutations in the CTNNB1 gene can provide a definitive diagnosis of MRD19. This is particularly important for families seeking to understand the cause of intellectual disability and for guiding potential treatment and management options. The test involves analyzing the DNA to identify mutations in the CTNNB1 gene that are known to be associated with the condition.
At DNA Labs UAE, a specialized genetic test for the CTNNB1 gene mutation is available. The cost of the test is 4400 AED. This testing process is crucial for families with a history of MRD19 or where there is a suspicion of the disorder based on clinical symptoms. A positive test result can help in the planning of educational and developmental support, inform about the risk of recurrence in future pregnancies, and potentially guide research into targeted therapies. DNA Labs UAE provides comprehensive support throughout the testing process, from sample collection to interpretation of results, ensuring that individuals and families receive the information and guidance they need.
The "DOCK8 Gene Mental Retardation Autosomal Dominant Type 2 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the DOCK8 gene, which are linked to a form of mental retardation known as Autosomal Dominant Mental Retardation Type 2. This condition is characterized by cognitive impairments and various developmental delays that are passed down through families in an autosomal dominant pattern, meaning only one copy of the altered gene in each cell is sufficient to cause the disorder.
The test involves analyzing the patient's DNA, extracted from a blood sample, to detect any abnormalities or mutations in the DOCK8 gene that could lead to the disorder. This genetic test is crucial for early diagnosis, which can help in the management and treatment of the condition, potentially improving the quality of life for those affected.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the cost of the DOCK8 Gene Mental Retardation Autosomal Dominant Type 2 Genetic Test is 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify gene mutations and provide reliable results. For families with a history of mental retardation or those experiencing related symptoms, this test offers a valuable resource for understanding their genetic makeup and making informed health decisions.
The MEF2C gene mental retardation autosomal dominant type 20 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the MEF2C gene, which are known to cause a form of intellectual disability known as autosomal dominant mental retardation type 20. This condition is characterized by developmental delays, intellectual challenges, potential speech impairments, and sometimes physical anomalies. The test involves analyzing the patient's DNA to detect any abnormalities or mutations in the MEF2C gene that could lead to the disorder.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test provides crucial information for families and healthcare providers, facilitating early intervention and tailored support strategies for affected individuals. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the MEF2C gene. This genetic test is a valuable tool in the management and understanding of autosomal dominant mental retardation type 20, offering hope and direction for affected families.
The SETD5 Gene Mental Retardation Autosomal Dominant Type 23 Genetic Test is a specific diagnostic tool aimed at identifying mutations in the SETD5 gene, which are associated with mental retardation autosomal dominant type 23 (MRD23). This condition is characterized by intellectual disabilities, developmental delays, and sometimes physical anomalies. The test is crucial for families seeking to understand the genetic basis of intellectual disabilities in their members, enabling targeted interventions and support.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to detect abnormalities in the SETD5 gene. The process requires a simple sample of the patient's blood or saliva, which is then examined using advanced genetic sequencing technologies.
The cost of the SETD5 Gene Mental Retardation Autosomal Dominant Type 23 Genetic Test is 4400 AED. This investment covers the comprehensive analysis necessary to provide a clear genetic diagnosis, which is essential for planning appropriate care and support for affected individuals. Families and healthcare providers opting for this test at DNA Labs UAE can expect results that are both accurate and actionable, contributing significantly to the management of conditions associated with mutations in the SETD5 gene.
The "DEAF1 Gene Mental Retardation Autosomal Dominant Type 24 Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting mutations in the DEAF1 gene, which are associated with Autosomal Dominant Mental Retardation Type 24. This condition, a form of intellectual disability, is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene in each cell is sufficient to cause the disorder. Symptoms can vary but often include developmental delays, learning disabilities, and sometimes physical abnormalities.
The test is crucial for families with a history of this condition, as it can provide a definitive diagnosis, informing medical management and support strategies for affected individuals. Additionally, it can be a vital tool for prospective parents concerned about passing the condition to their offspring, offering them the opportunity to make informed decisions about family planning.
DNA Labs UAE conducts this test with precision and care, ensuring confidentiality and support throughout the process. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the DEAF1 gene. This investment can provide invaluable insights for affected families, guiding them towards appropriate interventions and support services to improve quality of life for individuals with Autosomal Dominant Mental Retardation Type 24.
The AHDC1 gene is associated with Mental Retardation, Autosomal Dominant Type 25 (MRD25), a genetic disorder characterized by intellectual disability and often other neurological or physical abnormalities. The AHDC1 gene plays a crucial role in brain development, and mutations in this gene can lead to various developmental delays and cognitive impairments.
To diagnose this condition, a genetic test targeting the AHDC1 gene can be performed. This test is crucial for understanding the genetic basis of the intellectual disability in affected individuals and can assist in managing and planning for the needs of the individual.
In the UAE, DNA Labs UAE offers this specific genetic test. The cost of the AHDC1 gene test is 4400 AED. Conducting this test can provide families with vital information regarding the condition, potential interventions, and the likelihood of passing the mutation to future generations. It's a critical step towards personalized care and management for individuals with MRD25.
The SOX11 Gene Mental Retardation Autosomal Dominant Type 27 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SOX11 gene that are associated with Autosomal Dominant Non-Syndromic Intellectual Disability (ADNSID) Type 27. This condition, characterized by varying degrees of cognitive impairment and sometimes accompanied by other neurological or physical abnormalities, is inherited in an autosomal dominant manner, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
The SOX11 gene plays a crucial role in the development of the nervous system, and mutations in this gene can disrupt normal brain development, leading to intellectual disability. The test involves analyzing the patient's DNA, extracted from a blood sample, to detect mutations in the SOX11 gene that are known to cause the condition.
The cost of the SOX11 Gene Mental Retardation Autosomal Dominant Type 27 Genetic Test at DNA Labs UAE is 4400 AED. The test is a valuable resource for families seeking answers about intellectual disability and related conditions, providing essential information for diagnosis, management, and genetic counseling. By confirming a diagnosis, the test can help tailor educational and developmental support to the individual's needs and offer insights into the risk of passing the condition on to future generations.
The "ADNP Gene Mental Retardation Autosomal Dominant Type 28 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the ADNP gene, which have been linked to a rare form of autosomal dominant intellectual disability, known as Helsmoortel-Van der Aa syndrome. This condition is characterized by a wide range of symptoms including developmental delays, intellectual disability, speech impairments, and sometimes autism spectrum disorders. The test is crucial for families seeking a definitive diagnosis to understand the genetic basis of the condition, enabling targeted interventions and support.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test provides a comprehensive analysis of the ADNP gene to detect any anomalies that might be responsible for the condition. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the gene. Results from this test can offer invaluable insights for affected individuals and their families, guiding them towards appropriate care and management strategies.
The CDH15 gene is associated with a condition known as Mental Retardation, Autosomal Dominant Type 3 (MRD3), a disorder characterized by intellectual disabilities and possibly other neurological or physical abnormalities. The CDH15 gene plays a critical role in the development and function of the brain, influencing cell-cell adhesion processes which are essential for proper neural development.
A genetic test for MRD3 linked to the CDH15 gene can provide crucial information for individuals suspected of having this condition or families with a history of intellectual disabilities. This test involves analyzing the DNA to identify mutations in the CDH15 gene that are responsible for the disorder. Early diagnosis through genetic testing can aid in managing the condition more effectively, allowing for tailored educational programs, therapy, and support to improve the quality of life for affected individuals.
In the UAE, DNA Labs offers a comprehensive genetic test for the CDH15 gene to diagnose Mental Retardation, Autosomal Dominant Type 3. The test cost is set at 4400 AED, reflecting the specialized nature of the analysis and the advanced technology used to detect mutations in the gene accurately. Conducted in a state-of-the-art facility, the test provides a reliable diagnosis, enabling healthcare professionals and families to take informed steps towards managing the condition.
